Klotho Neurosciences Inc. Ordinary Shares KLTO 深 沪
已收盘 10-03 16:00:00 美东时间
0.4917
+0.041
+9.02%
华盛通- 最 高0.492
- 今 开0.47
- 成交量 153.23万股
- 最 低 0.4523
- 昨 收 0.451
- 总市值 272.25万
- 52周最高 3.9099
- 市盈率 静 --
- 换手率 27.67%
- 52周最低 0.1135
- 委 比 -92.39%
- 总股本 553.70万
- 历史最高 13.10
- 量 比 0.35
- 振 幅 8.80%
- 历史最低 0.00
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Klotho Neurosciences to acquire select assets from Turn Biotechnologies
Klotho Neurosciences (NASDAQ:KLTO) said on Tuesday that it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies. Under the LOI, Klotho would acquire Turn's ERA ("Epi...
09-30 21:25
Klotho Neurosciences Faces Nasdaq Delisting Notice
The latest update is out from Klotho Neurosciences ( ($KLTO) ). On September 19...
09-26 04:54
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerati...
09-08 20:00
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Docusign Inc (NASDAQ:DOCU) rose sharply in pre-market trading after t...
09-05 17:20
Klotho Neurosciences Q2 EPS $(0.12) Down From $(0.03) YoY
Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.12) per share. This is a 300 percent decrease over losses of $(0.03) per share from the same period last year.
08-18 21:50
Klotho Neurosciences Highlights Pipeline Progress Toward $8B Neurodegenerative Market; Accelerates KLTO-202 Preclinical and IND-Enabling Studies
Key partnerships, regulatory progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeuticsNEW YORK, Aug. 18, 2025 /PRNewswire/ -- Klotho
08-18 20:37
Klotho Neurosciences shares are trading higher after the company announced it will partner with AAVnerGene to manufacture gene therapy assets.
Klotho Neurosciences shares are trading higher after the company announced it w...
07-23 02:51
Klotho Neurosciences Regains Nasdaq Compliance
Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 14, 2025...
07-19 05:27
Klotho Clears Nasdaq Hurdle—KLTO Stock Remains On The Big Board
Klotho Neurosciences' stock has full compliance with all continued listing requirements and will remain listed and traded on the Nasdaq.
07-16 23:39
Klotho Neurosciences Receives FDA Orphan Drug Designation
Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025...
07-11 05:27
